Athira Pharma Inc. (ATHA)
NASDAQ: ATHA
· Real-Time Price · USD
0.33
-0.03 (-8.33%)
At close: Jun 09, 2025, 3:59 PM
Athira Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.3 | -0.38 | -0.15 | -0.9 | -0.91 | -0.85 | -0.58 | -0.95 | -0.92 | -1.17 | -1.73 | -1.18 | -6.83 | -7.45 | -5.58 | -6.82 | -18.56 |
PEG Ratio | 0.01 | 0.01 | -0.02 | -0.62 | 0.22 | 0.05 | -0.05 | -0.06 | n/a | -0.02 | 0.05 | -0.04 | -0.6 | -1.56 | -0.53 | -0.13 | -4.45 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 55.92 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.30 | 0.50 | 0.30 | 1.16 | 0.90 | 0.71 | 0.50 | 0.61 | 0.45 | 0.51 | 0.43 | 0.41 | 1.68 | 1.52 | 1.04 | 1.09 | 1.81 |
P/FCF Ratio | -0.76 | -0.87 | -0.75 | -4.31 | -3.73 | -3.52 | -3.2 | -4.61 | -3.59 | -7.65 | -5.13 | -6.13 | -29.31 | -25.36 | -33.57 | -51.28 | -86.51 |
P/OCF Ratio | -0.76 | -0.87 | -0.75 | -4.31 | -3.73 | -3.52 | -3.21 | -4.62 | -3.62 | -7.65 | -5.19 | -6.18 | -30.62 | -26.79 | -33.98 | -52.08 | -90.11 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -15.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 7.26 | 4.18 | 2.95 | 3.97 | 5.03 | 5.37 | 6.24 | 8.87 | 9.57 | 9.68 | 22.31 | 26.40 | 28.42 | 28.32 | 25.46 | 38.05 | 69.28 |
Current Ratio | 7.26 | 4.18 | 2.95 | 3.97 | 5.03 | 5.37 | 6.24 | 8.87 | 9.57 | 9.68 | 22.31 | 26.40 | 28.42 | 28.07 | 25.46 | 38.05 | 69.28 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -15.71 | n/a | n/a | n/a | n/a | -24.45 | n/a | -11.69K | -9.39K | -17.83K | n/a | n/a |
Return on Equity | -0.24 | -0.33 | -0.5 | -0.32 | -0.25 | -0.21 | -0.21 | -0.16 | -0.12 | -0.11 | -0.06 | -0.09 | -0.06 | -0.05 | -0.05 | -0.04 | -0.02 |
Return on Assets | -0.21 | -0.26 | -0.33 | -0.24 | -0.2 | -0.17 | -0.18 | -0.14 | -0.11 | -0.1 | -0.06 | -0.08 | -0.06 | -0.05 | -0.05 | -0.04 | -0.02 |
Return on Invested Capital | -0.25 | -0.34 | -0.5 | -0.33 | -0.26 | -0.25 | -0.22 | -0.17 | -0.13 | -0.12 | -0.07 | -0.08 | -0.07 | -0.07 | -0.06 | -0.06 | -0.04 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.85 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -16.48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -16.48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -18.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -18.36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |